Literature DB >> 8821376

Cellular hybridization for BDNF, trkB, and NGF mRNAs and BDNF-immunoreactivity in rat forebrain after pilocarpine-induced status epilepticus.

R Schmidt-Kastner1, C Humpel, C Wetmore, L Olson.   

Abstract

The messenger RNAs (mRNAs) for the neurotrophins, brain-derived neurotrophic factor (BDNF), and nerve growth factor (NGF), are upregulated during epileptic seizure activity, as visualized by in situ hybridization techniques. Neurotrophins might be protective against excitotoxic cell stress, and the upregulation during seizures might provide such cell protection. In this study, a high dose of pilocarpine (300 mg/kg) was used to induce long-lasting, limbic motor status epilepticus and a selective pattern of brain damage. The regulation of BDNF, trkB, and NGF mRNA was studied by in situ hybridization at 1, 3, 6, and 24 h after induction of limbic motor status epilepticus. BDNF immunoreactivity was examined with an anti-peptide antibody and the neuropathological process studied in parallel. BDNF mRNA increased in hippocampus, neocortex, piriform cortex, striatum, and thalamus with a maximum at 3-6 h. Hybridization levels increased earlier in the resistant granule and CA1 cells as compared to the vulnerable CA3 neurons. BDNF immunoreactivity was elevated in dentate gyrus at 3-6 h. trkB mRNA increased in the entire hippocampus. NGF mRNA in hippocampus appeared in dentate gyrus at 3-6 h and declined in hilar neurons at 6-24 h. Cell damage was found in the CA3 area, entire basal cortex, and layers II/III of neocortex. Endogenous neurotrophins are upregulated during status epilepticus caused by pilocarpine, which is related to the coupling between neuronal excitation and trophic factor expression. This upregulation of neurotrophic factors may serve endogenous protective effects; however, the excessive levels of neuronal hyperexcitation resulting from pilocarpine seizures lead to cell damage which cannot be prevented by endogenous neurotrophins.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8821376     DOI: 10.1007/bf00230416

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  70 in total

1.  Laminar damage of neurons and astrocytes in neocortex and hippocampus of rat after long-lasting status epilepticus induced by pilocarpine.

Authors:  R Schmidt-Kastner; M Ingvar
Journal:  Epilepsy Res Suppl       Date:  1996

2.  Gene transfer and molecular cloning of the rat nerve growth factor receptor.

Authors:  M J Radeke; T P Misko; C Hsu; L A Herzenberg; E M Shooter
Journal:  Nature       Date:  1987 Feb 12-18       Impact factor: 49.962

3.  Molecular cloning and expression of brain-derived neurotrophic factor.

Authors:  J Leibrock; F Lottspeich; A Hohn; M Hofer; B Hengerer; P Masiakowski; H Thoenen; Y A Barde
Journal:  Nature       Date:  1989-09-14       Impact factor: 49.962

4.  The low affinity NGF receptor, p75, can collaborate with each of the Trks to potentiate functional responses to the neurotrophins.

Authors:  P A Hantzopoulos; C Suri; D J Glass; M P Goldfarb; G D Yancopoulos
Journal:  Neuron       Date:  1994-07       Impact factor: 17.173

5.  Nerve growth factor mRNA is expressed by GABAergic neurons in rat hippocampus.

Authors:  J C Lauterborn; T M Tran; P J Isackson; C M Gall
Journal:  Neuroreport       Date:  1993-12-13       Impact factor: 1.837

6.  Seizure-induced increases in NGF mRNA exhibit different time courses across forebrain regions and are biphasic in hippocampus.

Authors:  J C Lauterborn; P J Isackson; C M Gall
Journal:  Exp Neurol       Date:  1994-01       Impact factor: 5.330

7.  Rat beta-nerve growth factor sequence and site of synthesis in the adult hippocampus.

Authors:  S R Whittemore; P L Friedman; D Larhammar; H Persson; M Gonzalez-Carvajal; V R Holets
Journal:  J Neurosci Res       Date:  1988-08       Impact factor: 4.164

8.  Damage of substantia nigra pars reticulata during pilocarpine-induced status epilepticus in the rat: immunohistochemical study of neurons, astrocytes and serum-protein extravasation.

Authors:  R Schmidt-Kastner; C Heim; K H Sontag
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

9.  Photochemical stroke and brain-derived neurotrophic factor (BDNF) mRNA expression.

Authors:  M C Comelli; M S Seren; D Guidolin; R M Manev; M Favaron; J M Rimland; R Canella; A Negro; H Manev
Journal:  Neuroreport       Date:  1992-06       Impact factor: 1.837

10.  Neuroprotective effect of chronic infusion of basic fibroblast growth factor on seizure-associated hippocampal damage.

Authors:  Z Liu; P A D'Amore; M Mikati; A Gatt; G L Holmes
Journal:  Brain Res       Date:  1993-10-29       Impact factor: 3.252

View more
  18 in total

1.  (±)3,4-methylenedioxymethamphetamine ("ecstasy") treatment modulates expression of neurotrophins and their receptors in multiple regions of adult rat brain.

Authors:  Ann M Hemmerle; Jonathan W Dickerson; Nicole R Herring; Tori L Schaefer; Charles V Vorhees; Michael T Williams; Kim B Seroogy
Journal:  J Comp Neurol       Date:  2012-08-01       Impact factor: 3.215

2.  Activity-dependent dendritic targeting of BDNF and TrkB mRNAs in hippocampal neurons.

Authors:  E Tongiorgi; M Righi; A Cattaneo
Journal:  J Neurosci       Date:  1997-12-15       Impact factor: 6.167

3.  The histone lysine demethylase Kdm6b is required for activity-dependent preconditioning of hippocampal neuronal survival.

Authors:  Ranjula Wijayatunge; Liang-Fu Chen; Young May Cha; Anthony S Zannas; Christopher L Frank; Anne E West
Journal:  Mol Cell Neurosci       Date:  2014-06-28       Impact factor: 4.314

4.  Plasticity of presynaptic and postsynaptic serotonin 1A receptors in an animal model of epilepsy-associated depression.

Authors:  Eduardo A Pineda; Julie G Hensler; Raman Sankar; Don Shin; Teresa F Burke; Andréy M Mazarati
Journal:  Neuropsychopharmacology       Date:  2011-02-23       Impact factor: 7.853

5.  Brain-derived neurotrophic factor transgenic mice exhibit passive avoidance deficits, increased seizure severity and in vitro hyperexcitability in the hippocampus and entorhinal cortex.

Authors:  S D Croll; C Suri; D L Compton; M V Simmons; G D Yancopoulos; R M Lindsay; S J Wiegand; J S Rudge; H E Scharfman
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

6.  TrkB/BDNF-dependent striatal plasticity and behavior in a genetic model of epilepsy: modulation by valproic acid.

Authors:  Veronica Ghiglieri; Carmelo Sgobio; Stefano Patassini; Vincenza Bagetta; Anna Fejtova; Carmela Giampà; Silvia Marinucci; Alexandra Heyden; Eckart D Gundelfinger; Francesca R Fusco; Paolo Calabresi; Barbara Picconi
Journal:  Neuropsychopharmacology       Date:  2010-03-03       Impact factor: 7.853

7.  Comparison of three hypothermic target temperatures for the treatment of hypoxic ischemia: mRNA level responses of eight genes in the piglet brain.

Authors:  Linus Olson; Stuart Faulkner; Karin Lundströmer; Aron Kerenyi; Dorka Kelen; M Chandrasekaran; Ulrika Ådén; Lars Olson; Xavier Golay; Hugo Lagercrantz; Nicola J Robertson; Dagmar Galter
Journal:  Transl Stroke Res       Date:  2012-10-14       Impact factor: 6.829

8.  Status epilepticus: Using antioxidant agents as alternative therapies.

Authors:  Liliana Carmona-Aparicio; Cecilia Zavala-Tecuapetla; María Eva González-Trujano; Aristides Iii Sampieri; Hortencia Montesinos-Correa; Leticia Granados-Rojas; Esaú Floriano-Sánchez; Elvia Coballase-Urrutía; Noemí Cárdenas-Rodríguez
Journal:  Exp Ther Med       Date:  2016-08-23       Impact factor: 2.447

9.  Prenatal choline supplementation attenuates neuropathological response to status epilepticus in the adult rat hippocampus.

Authors:  Sarah J E Wong-Goodrich; Tiffany J Mellott; Melissa J Glenn; Jan K Blusztajn; Christina L Williams
Journal:  Neurobiol Dis       Date:  2008-02-16       Impact factor: 5.996

10.  Sexual dimorphism in BDNF signaling after neonatal hypoxia-ischemia and treatment with necrostatin-1.

Authors:  R Chavez-Valdez; L J Martin; S Razdan; E B Gauda; F J Northington
Journal:  Neuroscience       Date:  2013-12-17       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.